Spadaccini, MarcoHassan, CesareRondonotti, EmanueleAntonelli, GiulioAndrisani, GianlucaLollo, GianlucaAuriemma, FrancescoIacopini, FedericoFacciorusso, AntonioMaselli, RobertaFugazza, AlessandroBambina Bergna, Irene MariaCereatti, FabrizioMangiavillano, BenedettoRadaelli, FrancoDi Matteo, FrancescoGross, Seth A.Sharma, PrateekMori, YuichiBretthauer, MichaelRex, Douglas K.Repici, Alessandro2023-08-252023-08-252023-07Spadaccini, M., Hassan, C., Rondonotti, E., Antonelli, G., Andrisani, G., Lollo, G., Auriemma, F., Iacopini, F., Facciorusso, A., Maselli, R., Fugazza, A., Bambina Bergna, I. M., Cereatti, F., Mangiavillano, B., Radaelli, F., Di Matteo, F., Gross, S. A., Sharma, P., Mori, Y., … Schilirò, A. (2023). Combination of mucosa-exposure device and computer-aided detection for Adenoma Detection during Colonoscopy: A randomized trial. Gastroenterology, 165(1), P244-251.E3. https://doi.org/10.1053/j.gastro.2023.03.23737061169https://hdl.handle.net/1805/35151Background & Aims Both computer-aided detection (CADe)-assisted and Endocuff-assisted colonoscopy have been found to increase adenoma detection. We investigated the performance of the combination of the 2 tools compared with CADe-assisted colonoscopy alone to detect colorectal neoplasias during colonoscopy in a multicenter randomized trial. Methods Men and women undergoing colonoscopy for colorectal cancer screening, polyp surveillance, or clincial indications at 6 centers in Italy and Switzerland were enrolled. Patients were assigned (1:1) to colonoscopy with the combinations of CADe (GI-Genius; Medtronic) and a mucosal exposure device (Endocuff Vision [ECV]; Olympus) or to CADe-assisted colonoscopy alone (control group). All detected lesions were removed and sent to histopathology for diagnosis. The primary outcome was adenoma detection rate (percentage of patients with at least 1 histologically proven adenoma or carcinoma). Secondary outcomes were adenomas detected per colonoscopy, advanced adenomas and serrated lesions detection rate, the rate of unnecessary polypectomies (polyp resection without histologically proven adenomas), and withdrawal time. Results From July 1, 2021 to May 31, 2022, there were 1316 subjects randomized and eligible for analysis; 660 to the ECV group, 656 to the control group). The adenoma detection rate was significantly higher in the ECV group (49.6%) than in the control group (44.0%) (relative risk, 1.12; 95% CI, 1.00–1.26; P = .04). Adenomas detected per colonoscopy were significantly higher in the ECV group (mean ± SD, 0.94 ± 0.54) than in the control group (0.74 ± 0.21) (incidence rate ratio, 1.26; 95% CI, 1.04–1.54; P = .02). The 2 groups did not differ in term of detection of advanced adenomas and serrated lesions. There was no significant difference between groups in mean ± SD withdrawal time (9.01 ± 2.48 seconds for the ECV group vs 8.96 ± 2.24 seconds for controls; P = .69) or proportion of subjects undergoing unnecessary polypectomies (relative risk, 0.89; 95% CI, 0.69–1.14; P = .38). Conclusions The combination of CADe and ECV during colonoscopy increases adenoma detection rate and adenomas detected per colonoscopy without increasing withdrawal time compared with CADe alone.enPublisher PolicyCancerColonoscopyInnovationScreeningTechnologyArticle